Home › Urothelial (Transitional Cell) Carcinoma › New York › Queens
Urothelial (Transitional Cell) Carcinoma clinical trials in Queens, NY
15 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in and around Queens (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- START New York Long Island LLC, Lake Success · 9 mi away
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi away
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RecruitingObservational study
- The Feinstein Institutes for Medical Research, Lake Success · 9 mi away
DBC-664 in Adult Patients With Solid Tumors
RecruitingPhase 1
- START New York, Lake Success · 9 mi away
Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
RecruitingPhase 2
- Memorial Sloan Kettering Nassau, Rockville Centre · 10 mi away
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
RecruitingPhase 1
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi away
A Study of GEN1106 in Participants With Solid Tumors
RecruitingPhase 1
- START New York Long Island LLC, Lake Success · 9 mi away
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RecruitingPhase 1
- NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola · 11 mi away
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
RecruitingPhase 1/2
- START New York Long Island, New Hyde Park · 9 mi away
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RecruitingPhase 1/2
- Clinical Research Alliance, Inc, Westbury · 14 mi away
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RecruitingPhase 2
- MSK nassau, Uniondale · 13 mi away
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
RecruitingPhase 1
- Start New York, LLC, Lake Success · 9 mi away
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
RecruitingObservational study
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 mi away
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
RecruitingPhase 1
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Hempstead · 12 mi away
Urothelial (Transitional Cell) Carcinoma trials in other cities
- Nashville, TN23 studies
- New York City, NY22 studies
- Dallas, TX18 studies
- Edison, NJ18 studies
- Houston, TX18 studies
- Los Angeles, CA17 studies
- Chicago, IL14 studies
- Arlington, VA12 studies
- San Antonio, TX11 studies
- Boston, MA11 studies
- Austin, TX10 studies
- Orange, CA10 studies
Other studies in Queens
- Breast Cancer63 studies
- Non-Small Cell Lung Cancer49 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Ovarian Cancer28 studies
- Prostate Cancer27 studies
- Cancer (all types)26 studies
- Endometrial Cancer25 studies
- Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Head and Neck Squamous Cell Carcinoma20 studies
- Multiple Myeloma20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.